United Kingdom Poultry Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Type (Attenuated /Live Vaccines, Inactivated Vaccines, and Others), By Application (Broiler, Layer, and Breeder), and UK Poultry Vaccines Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Poultry Vaccines Market Size Forecasts to 2035

• The United Kingdom Poultry Vaccines Market Size Was Estimated at USD 172.8 Million in 2024
• The UK Poultry Vaccines Market Size is Expected to Grow at a CAGR of around 6.52% from 2025 to 2035
• The UK Poultry Vaccines Market Size is Expected to Reach USD 346.1 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, the UK Poultry Vaccines Market Size is anticipated to reach USD 346.1 million by 2035, growing at a CAGR of 6.52% from 2025 to 2035. Growing disease incidence, advancements in vectored and combination vaccines, and government financing for extensive vaccination campaigns and innovative initiatives are the main factors propelling the market.

Market Overview

The UK poultry vaccines market includes the UK production and delivery of vaccines to protect poultry against disease. These vaccines are crucial for enhancing chicken health, boosting production, and ensuring a safe and sustainable food supply chain. Poultry farmers' growing emphasis on biosecurity and disease prevention is driving growth in the UK poultry vaccines market. Effective vaccines are in high demand due to growing awareness of the need to control avian diseases like infectious bursal disease and Newcastle. the rising incidence of infectious bronchitis, a serious problem, is expected to drive growth in the UK poultry vaccines market. IBV is still the most economically important chicken disease, according to The Pirbright Institute, and the present egg-based vaccine production process is expensive and time-consuming, underscoring the need for innovation. The development of novel, multi-antigen vaccines that streamline administration and support sustainability objectives by lowering the use of antibiotics presents opportunities. In order to improve flock productivity and health, customised vaccination regimens that are adapted to specific farm conditions are becoming more widespread. Furthermore, accurate health monitoring and scheduling made possible by digital technologies and data analytics are improving vaccination efforts. In the UK, these patterns show a move towards ethical, effective, and sustainable poultry farming.

Report Coverage

This research report categorizes the market for the UK poultry vaccines market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom poultry vaccines market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom poultry vaccines market.

Driving Factors

The growing demand for chicken products high in protein is driving the UK poultry vaccines market, as producers are using vaccination to increase production efficiency. This trend is supported by the government's commitment to sustainable agriculture and food security. Farmers are additionally compelled to implement vaccination procedures by stringent animal health restrictions. Furthermore, preventive immunisation is required to prevent supply chain disruptions and financial losses due to the rising prevalence of chicken diseases as Newcastle disease and avian influenza. Adoption of vaccines is reinforced by industry associations' and public health organisations' support, which drives market expansion.

Restraining Factors

A primary restraining factor in the UK poultry vaccines market is the high cost and complexity of developing vaccines, especially for infectious bronchitis. Producing egg-based vaccines is time-consuming and costly. The limited efficacy against emerging strains, along with issues related to distribution, may lead to difficulties in adoption by smaller poultry farms. These factors hamper the poultry vaccines market during the forecast period.

Market Segmentation

The United Kingdom poultry vaccines market share is classified into vaccine type and application.

• The attenuated /live vaccines segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom poultry vaccines market is segmented by vaccine type into attenuated /live vaccines, inactivated vaccines, and others. Among these, the attenuated /live vaccines segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Compared to inactivated vaccinations, attenuated live vaccines provide strong immunity with fewer doses. This is especially helpful in managing extremely contagious illnesses like Marek's disease, Newcastle disease, and Infectious Bursal disease (IBD). Furthermore, large-scale chicken farms can use these vaccinations for mass vaccination.

• The breeder segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom poultry vaccines market is segmented by application into broiler, layer, and breeder. Among these, the breeder segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. With the increased output from these breeding facilities, the market has expanded. The market expansion is also a result of several government initiatives that incentivise breeders to vaccinate their chickens, protecting the vaccinated birds as well as their progeny, or broilers. Additionally, breeders can vaccinate and monitor their animals for longer periods because their production cycles are longer than those of layers.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom poultry vaccines market and a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Hipra
• MediVet
• Ceva Sante Animale
• Valogen
• Zoetis
• Vetoquinol
• Elanco Animal Health
• Hester Biosciences
• Petersime
• IDT Biologika
• Merck Animal Health
• MSD Animal Health
• Poultry Health Services
• Boehringer Ingelheim
• Others

Key Target Audience

• Investors
• Market players
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom poultry vaccines market based on the below-mentioned segments:

United Kingdom Poultry Vaccines Market, By Vaccine Type

• Attenuated /Live Vaccines
• Inactivated Vaccines
• Others

United Kingdom Poultry Vaccines Market, By Application

• Broiler
• Layer
• Breeder